# OnCo record pamrevlumab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/pamrevlumab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "pamrevlumab" ;
  schema:name "Pamrevlumab"@en ;
  schema:alternateName "FG-3019"@en ;
  schema:description "Pamrevlumab targeted the scar-like tissue around pancreatic tumours; its phase 3 LAPIS trial in locally advanced disease did not lengthen survival."@en ;
  schema:url <https://onco.cc/drugs/pamrevlumab/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03941093>, <https://investor.fibrogen.com/news-releases> ;
  onco:status "negative" ;
  onco:modality "Monoclonal antibody against connective tissue growth factor (CTGF)" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:companies <https://onco.cc/companies/fibrogen/> ;
  onco:trials <https://onco.cc/trials/lapis-trial/> .
